← Open Payments lookup

MICHAEL SALINAS: Open Payments

NPI 1336530252 · SOUTHGATE, MI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$1,112 in 74 payments from 12 companies in 2025. Trend: 2023 $1,082 · 2024 $496 · 2025 $1,112

Food & beverage: $1,112
CompanyPaymentsAmount
Vanda Pharmaceuticals Inc.18$183
Neurocrine BioSciences, Inc.8$163
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)17$148
E.R. Squibb & Sons, L.L.C.12$138
Janssen Pharmaceuticals, Inc2$135
Lundbeck LLC5$115
Alkermes, Inc.4$75
Otsuka America Pharmaceutical, Inc.3$51
ABBVIE INC.2$40
Teva Pharmaceuticals USA, Inc.1$27

Products named: INGREZZA, CAPLYTA, COBENFY, INVEGA SUSTENNA, FANAPT, REXULTI, ARISTADA, HETLIOZ.

Industry payments across MI — which companies pay providers there.